Banner - NPPA Connect

Opinion|Videos|August 16, 2024

Navigating the Treatment Paradigm for Vitiligo: Efficacy, MOA, and Long-Term Use of FDA-Approved Topical Ruxolitinib

Author(s)Ted Lain, MD, MBA, FAAD

Ted Lain, MD, MBA, FAAD discusses navigating the treatment paradigm for vitiligo.

Episodes in this series

EP. 1 Insights into Navigating the Emotional and Clinical Challenges in Vitiligo Management

EP. 1 Insights into Navigating the Emotional and Clinical Challenges in Vitiligo Management

EP. 2 Balancing Vitiligo Treatments with Coverage Challenges

EP. 2 Balancing Vitiligo Treatments with Coverage Challenges

EP. 3 Case-Based Insights: Addressing Location-Specific Concerns and Treatment Challenges in Vitiligo Management

EP. 3 Case-Based Insights: Addressing Location-Specific Concerns and Treatment Challenges in Vitiligo Management

EP. 4 Navigating the Treatment Paradigm for Vitiligo: Efficacy, MOA, and Long-Term Use of FDA-Approved Topical Ruxolitinib

EP. 4 Navigating the Treatment Paradigm for Vitiligo: Efficacy, MOA, and Long-Term Use of FDA-Approved Topical Ruxolitinib

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

A New Perspective on Seborrheic Dermatitis Management

ByMarie Bosslett, Assistant Editor

September 11th 2025

How to Individualize Biologic Therapy in Severe Prurigo Nodularis

ByKaitlyn Bader, Assistant Managing Editor

August 27th 2025

1 expert in this video

Importance of Shared Decision-Making and Tailored Treatment in Psoriasis Care

ByOmar Noor, MD, FAAD

August 6th 2025

1 expert in this video

Involving the Patient in Their Psoriasis Treatment With a 42-Year-Old Woman With a Busy Lifestyle

ByOmar Noor, MD, FAAD

August 6th 2025

1 expert in this video

Incorporating Patient Lifestyle into Treatment Decisions in a 64-Year-Old Man with Late-Onset Psoriasis

ByOmar Noor, MD, FAAD

August 6th 2025

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline

Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria

10 Skin Cancer Exam Tips

Dermatology Times Conferences & Meetings Calendar: September 2026

Early Recognition and Psychosocial Impact in Male Pattern Hair Loss